Skip to main content

Advertisement

Log in

Difficult to treat: are there organism-dependent differences and overall risk factors in success rates for two-stage knee revision?

  • Orthopaedic Surgery
  • Published:
Archives of Orthopaedic and Trauma Surgery Aims and scope Submit manuscript

Abstract

Objectives

Failure after two-stage procedure for periprosthetic joint infection (PJI) is a rare, but devastating complication. Some authors assume a correlation of underlying organisms and recurrence rate. Methicillin-resistant Staphylococci (MRS) and other organisms (quinolone-resistant Gram-negative bacteria, rifampicin-resistant Staphylococcus, Enterococcus, and Candida) are meant to be “difficult to treat” (DTT) with an inferior outcome for two-stage revision. In addition to the type of bacteria, some more risk factors seem to be present. The aim of this study was (1) to detect a difference of reinfection rates between reinfection-causing groups of bacteria [“difficult to treat” (DTT), “easy to treat” (ETT) and methicillin-resistant staphylococci (MRS)] after a two-stage procedure, and (2) find overall risk factors for reinfection in a standardized long (spacer insertion for at least 6 weeks) two-stage procedure for periprosthetic knee infection.

Methods

One hundred and thirty-seven two-stage revisions for periprosthetic knee infection were performed at one tertiary referral center. Finally, 96 patients could be included for analyses. Possible risk factors (comorbidities, prior surgery, etc.) and the types of organisms were documented. Quinolone-resistant Gram-negative bacteria, rifampicin-resistant Staphylococcus, Enterococcus, and Candida were classified as “difficult to treat” (DTT). Methicillin-resistant Staphylococci were summarized as “MRS”, all other organism are summarized as “easy to treat” (ETT). Statistical analyses included univariate analysis (t test, Fisher’s exact test, Chi square test) and logistic regression analysis.

Results

There were no statistical significant differences in recurrent infection rates between organism groups (DTT vs. ETT, p = 0.674; DTT vs. MRS, p = 0.705; ETT vs. MRS, p = 0.537). Risk factors seem to be “need of revision after first stage” (p = 0.019, OR 5.62) or completed second stage (p = 0.000, OR 29.07), numbers of surgeries (p = 0.028) and alcohol abuse (p = 0.019, OR 5.62).

Conclusions

Revision needed during or after a two-stage exchange, numbers of surgeries and alcohol abuse are risk factors for recurrence, a different recurrence rates between organism-groups cannot be shown. The absence of significant differences in recurrence rates points to the importance of the individuality of each periprosthetic infection case: a reduction of necessary surgeries (with a thorough debridement, appropriate antibiotic addition to spacers) and the control of comorbidities (alcohol abuse) appear to be essential components of a two-stage exchange.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Berend KR, Lombardi AV Jr, Morris MJ, Bergeson AG, Adams JB, Sneller MA (2013) Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality. Clin Orthop Relat Res 471(2):510–518. https://doi.org/10.1007/s11999-012-2595-x

    Article  PubMed  Google Scholar 

  2. Lenguerrand E, Whitehouse MR, Beswick AD, Toms AD, Porter ML, Blom AW, National Joint Registry for England WNI, the Isle of Man (2017) Description of the rates, trends and surgical burden associated with revision for prosthetic joint infection following primary and revision knee replacements in England and Wales: an analysis of the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man. BMJ Open 7(7):e014056. https://doi.org/10.1136/bmjopen-2016-014056

    Article  PubMed  PubMed Central  Google Scholar 

  3. Delanois RE, Mistry JB, Gwam CU, Mohamed NS, Choksi US, Mont MA (2017) Current epidemiology of revision total knee arthroplasty in the United States. J Arthroplast 32(9):2663–2668. https://doi.org/10.1016/j.arth.2017.03.066

    Article  Google Scholar 

  4. Boddapati V, Fu MC, Mayman DJ, Su EP, Sculco PK, McLawhorn AS (2018) Revision total knee arthroplasty for periprosthetic joint infection is associated with increased postoperative morbidity and mortality relative to noninfectious revisions. J Arthroplast 33(2):521–526. https://doi.org/10.1016/j.arth.2017.09.021

    Article  Google Scholar 

  5. Masters JP, Smith NA, Foguet P, Reed M, Parsons H, Sprowson AP (2013) A systematic review of the evidence for single stage and two stage revision of infected knee replacement. BMC Musculoskelet Disord 14:222

    Article  Google Scholar 

  6. Parvizi J, Cavanaugh PK, Diaz-Ledezma C (2013) Periprosthetic knee infection: ten strategies that work. Knee Surg Relat Res 25(4):155–164. https://doi.org/10.5792/ksrr.2013.25.4.155

    Article  PubMed  PubMed Central  Google Scholar 

  7. Cochran AR, Ong KL, Lau E, Mont MA, Malkani AL (2016) Risk of reinfection after treatment of infected total knee arthroplasty. J Arthroplast 31(9 Suppl):156–161. https://doi.org/10.1016/j.arth.2016.03.028

    Article  Google Scholar 

  8. Yu Q, Luo M, Wu S, Lai A, Sun Y, Hu Q, He Y, Tian J (2019) Comparison of infection eradication rate of using articulating spacers containing bio-inert materials versus all-cement articulating spacers in revision of infected TKA: a systematic review and meta-analysis. Arch Orthop Trauma Surg 139(5):695–707. https://doi.org/10.1007/s00402-019-03121-x

    Article  PubMed  Google Scholar 

  9. Akgun D, Muller M, Perka C, Winkler T (2018) An often-unrecognized entity as cause of recurrent infection after successfully treated two-stage exchange arthroplasty: hematogenous infection. Arch Orthop Trauma Surg 138(9):1199–1206. https://doi.org/10.1007/s00402-018-2972-3

    Article  PubMed  Google Scholar 

  10. Sakellariou VI, Poultsides LA, Vasilakakos T, Sculco P, Ma Y, Sculco TP (2015) Risk factors for recurrence of periprosthetic knee infection. J Arthroplast. https://doi.org/10.1016/j.arth.2015.04.005

    Article  Google Scholar 

  11. Sabry FY, Buller L, Ahmed S, Klika AK, Barsoum WK (2014) Preoperative prediction of failure following two-stage revision for knee prosthetic joint infections. J Arthroplast 29(1):115–121. https://doi.org/10.1016/j.arth.2013.04.016

    Article  Google Scholar 

  12. Winkler T, Trampuz A, Hardt S, Janz V, Kleber C, Perka C (2014) Periprosthetic infection after hip arthroplasty. Der Orthopade 43(1):70–78. https://doi.org/10.1007/s00132-013-2132-y

    Article  CAS  PubMed  Google Scholar 

  13. Holleyman RJ, Deehan DJ, Walker L, Charlett A, Samuel J, Shirley MDF, Baker PN (2019) Staphylococcal resistance profiles in deep infection following primary hip and knee arthroplasty: a study using the NJR dataset. Arch Orthop Trauma Surg 139(9):1209–1215. https://doi.org/10.1007/s00402-019-03155-1

    Article  PubMed  PubMed Central  Google Scholar 

  14. Parry MC, Duncan CP (2014) The challenge of methicillin resistant staphylococcal infection after total hip replacement. Bone Joint J 96:60–65. https://doi.org/10.1302/0301-620X.96B11

    Article  PubMed  Google Scholar 

  15. Akgun D, Perka C, Trampuz A, Renz N (2018) Outcome of hip and knee periprosthetic joint infections caused by pathogens resistant to biofilm-active antibiotics: results from a prospective cohort study. Arch Orthop Trauma Surg 138(5):635–642. https://doi.org/10.1007/s00402-018-2886-0

    Article  PubMed  Google Scholar 

  16. Zimmerli W, Moser C (2012) Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol Med Microbiol 65(2):158–168. https://doi.org/10.1111/j.1574-695X.2012.00938.x

    Article  CAS  PubMed  Google Scholar 

  17. Chen AF, Heller S, Parvizi J (2014) Prosthetic joint infections. Surg Clin N Am 94(6):1265–1281. https://doi.org/10.1016/j.suc.2014.08.009

    Article  PubMed  Google Scholar 

  18. Parvizi J, Gehrke T, International Consensus Group on Periprosthetic Joint Infection (2014) Definition of periprosthetic joint infection. J Arthroplast 29(7):1331. https://doi.org/10.1016/j.arth.2014.03.009

    Article  Google Scholar 

  19. Faschingbauer M, Bieger R, Reichel H, Weiner C, Kappe T (2015) Complications associated with 133 static, antibiotic-laden spacers after TKA. Knee Surg Sports Traumatol Arthrosc. https://doi.org/10.1007/s00167-015-3646-0

    Article  PubMed  Google Scholar 

  20. Frank JM, Kayupov E, Moric M, Segreti J, Hansen E, Hartman C, Okroj K, Belden K, Roslund B, Silibovsky R, Parvizi J, Della Valle CJ, Knee Society Research Group (2017) The Mark Coventry, MD, Award: oral antibiotics reduce reinfection after two-stage exchange: a multicenter, randomized controlled trial. Clin Orthop Relat Res 475(1):56–61. https://doi.org/10.1007/s11999-016-4890-4

    Article  PubMed  Google Scholar 

  21. Hipfl C, Winkler T, Janz V, Perka C, Müller M (2019) Management of chronically infected total knee arthroplasty with severe bone loss using static spacers with intramedullary rods. J Arthroplast 34:1462–1469. https://doi.org/10.1016/j.arth.2019.03.053

    Article  Google Scholar 

  22. Salgado CD, Dash S, Cantey JR, Marculescu CE (2007) Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res 461:48–53. https://doi.org/10.1097/BLO.0b013e3181123d4e

    Article  PubMed  Google Scholar 

  23. Nodzo SR, Boyle KK, Spiro S, Nocon AA, Miller AO, Westrich GH (2017) Success rates, characteristics, and costs of articulating antibiotic spacers for total knee periprosthetic joint infection. Knee 24(5):1175–1181. https://doi.org/10.1016/j.knee.2017.05.016

    Article  PubMed  Google Scholar 

  24. Baldoni D, Haschke M, Rajacic Z, Zimmerli W, Trampuz A (2009) Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection. Antimicrob Agents Chemother 53(3):1142–1148. https://doi.org/10.1128/AAC.00775-08

    Article  CAS  PubMed  Google Scholar 

  25. John AK, Baldoni D, Haschke M, Rentsch K, Schaerli P, Zimmerli W, Trampuz A (2009) Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin. Antimicrob Agents Chemother 53(7):2719–2724. https://doi.org/10.1128/AAC.00047-09

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Corvec S, Furustrand Tafin U, Betrisey B, Borens O, Trampuz A (2013) Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-beta-lactamase-producing Escherichia coli in a foreign-body infection model. Antimicrob Agents Chemother 57(3):1421–1427. https://doi.org/10.1128/AAC.01718-12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Furustrand Tafin U, Majic I, Zalila Belkhodja C, Betrisey B, Corvec S, Zimmerli W, Trampuz A (2011) Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother 55(10):4821–4827. https://doi.org/10.1128/AAC.00141-11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Oliva A, Furustrand Tafin U, Maiolo EM, Jeddari S, Betrisey B, Trampuz A (2014) Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model. Antimicrob Agents Chemother 58(3):1284–1293. https://doi.org/10.1128/AAC.02583-12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Ma CY, Lu YD, Bell KL, Wang JW, Ko JY, Wang CJ, Kuo FC (2018) Predictors of treatment failure after 2-stage reimplantation for infected total knee arthroplasty: a 2- to 10-year follow-up. J Arthroplast 33:2234–2239. https://doi.org/10.1016/j.arth.2018.02.007

    Article  Google Scholar 

  30. Schwarzkopf R, Oh D, Wright E, Estok DM, Katz JN (2013) Treatment failure among infected periprosthetic patients at a highly specialized revision TKA referral practice. Open Orthop J 7:264–271

    Article  Google Scholar 

  31. Baldoni D, Furustrand Tafin U, Aeppli S, Angevaare E, Oliva A, Haschke M, Zimmerli W, Trampuz A (2013) Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model. Int J Antimicrob Agents 42(3):220–225. https://doi.org/10.1016/j.ijantimicag.2013.05.019

    Article  CAS  PubMed  Google Scholar 

  32. Mihailescu R, Furustrand Tafin U, Corvec S, Oliva A, Betrisey B, Borens O, Trampuz A (2014) High activity of Fosfomycin and Rifampin against methicillin-resistant Staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother 58(5):2547–2553. https://doi.org/10.1128/AAC.02420-12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Maiolo EM, Furustrand Tafin U, Borens O, Trampuz A (2014) Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry. Antimicrob Agents Chemother 58(5):2709–2717. https://doi.org/10.1128/AAC.00057-14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Jung SH (2014) Stratified Fisher’s exact test and its sample size calculation. Biom J 56(1):129–140. https://doi.org/10.1002/bimj.201300048

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

FM: planning/conception of the study, collection of data, analysis and interpretation, statistical analysis, writing and revising article; (orthopedic surgeon). WC: collection of data, analysis and interpretation, statistical analysis; (student). BR, KT, FT: collection of data, critical revision of the article; (orthopedic surgeons). RH: critical revision of the article, final approval of the article, overall responsibility; (surgeon in chief University of Ulm).

Corresponding author

Correspondence to Martin Faschingbauer.

Ethics declarations

Conflict of interest

We certify that we have not signed any agreement with commercial interest related to this study, which would in any way limit publication of any and all data generated for the study or to delay publication for any reason. Dr. Faschingbauer reports personal fees from Deutsche Forschungsgemeinschaft (Research Fellowship, FA 1271/1-1, http://www.dfg.de), during the conduct of the study.

Ethical statement

The authors’ institutional review board approved this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Faschingbauer, M., Bieger, R., Kappe, T. et al. Difficult to treat: are there organism-dependent differences and overall risk factors in success rates for two-stage knee revision?. Arch Orthop Trauma Surg 140, 1595–1602 (2020). https://doi.org/10.1007/s00402-020-03335-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00402-020-03335-4

Keywords

Navigation